In 2011, year-over-year executive cash compensation increased just 1.6%, well below the historical 5% annual rise, according to a nationwide survey.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
The author would like to thank Evan Brown at extensionEngine LLC (http://www.extensionengine.com/) for his contributions to the CompStudy report and this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Rychlik, B. Pay increases for executives at private life sciences companies hit a 12-year low. Nat Biotechnol 30, 289–291 (2012). https://doi.org/10.1038/nbt.2155
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2155